A.R.T. Advisors’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-17,497	Closed	-$278K	–	1422
2017 Q3	$278K	Buy	17,497 +1,101	+7%	+$17.5K	0.01%	1037
2017 Q2	$198K	Buy	+16,396	New	+$198K	0.01%	1162